drugset / Trial / NCT01609179
IPI-926 Extension Protocol for Continuation of Treatment With IPI-926
NaSingle-groupOpen-labelTreatment
Summary
A treatment protocol that enables patients to have continued access to IPI-926.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-10
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Patidegib | Small molecule | 60 mg | Oral |
| Subject | Patidegib | Small molecule | 90 mg | Oral |
| Subject | Patidegib | Small molecule | 100 mg | Oral |
| Subject | Patidegib | Small molecule | 110 mg | Oral |
| Subject | Patidegib | Small molecule | 130 mg | Oral |
| Subject | Patidegib | Small molecule | 160 mg | Oral |